The Activating Human NK Cell Receptor KIR2DS2 Recognizes a β2-Microglobulin–Independent Ligand on Cancer Cells
Open Access
- 1 April 2017
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 198 (7) , 2556-2567
Abstract
The functions of activating members of the killer cell Ig-like receptor (KIR) family are not fully understood, as the ligands for these receptors are largely unidentified. In this study, we report that KIR2DS2 reporter cells recognize a ligand expressed by cancer cell lines. All cancer targets recognized by KIR2DS2 were also recognized by KIR2DL2 and KIR2DL3 reporters. Trogocytosis of membrane proteins from the cancer targets was observed with responding reporter cells, indicating the formation of KIR2DS2 ligand–specific immunological synapses. HLA-C typing of target cells showed that KIR2DS2 recognition was independent of the HLA C1 or C2 group, whereas targets cells that were only recognized by KIR2DL3 expressed C1 group alleles. Anti–HLA class I Abs blocked KIR2DL3 responses toward C1-expressing targets, but they did not block KIR2DS2 recognition of cancer cells. Small interfering RNA knockdown of β2-microglobulin reduced the expression of class I H chain on the cancer targets by >97%, but it did not reduce the KIR2DS2 reporter responses, indicating a β2-microglobulin–independent ligand for KIR2DS2. Importantly, KIR2DL3 responses toward some KIR2DS2 ligand–expressing cells were also undiminished after β2-microglobulin knockdown, and they were not blocked by anti–HLA class I Abs, suggesting that KIR2DL3, in addition to the traditional HLA-C ligands, can bind to the same β2-microglobulin–independent ligand as KIR2DS2. These observations indicate the existence of a novel, presently uncharacterized ligand for the activating NK cell receptor KIR2DS2. Molecular identification of this ligand may lead to improved KIR-HLA mismatching in hematopoietic stem cell transplantation therapy for leukemia and new, more specific NK cell–based cancer therapies.Keywords
This publication has 61 references indexed in Scilit:
- HLA-F and MHC Class I Open Conformers Are Ligands for NK Cell Ig-like ReceptorsThe Journal of Immunology, 2013
- Paired opposing leukocyte receptors recognizing rapidly evolving ligands are subject to homogenization of their ligand binding domainsImmunogenetics, 2011
- HLA-F Complex without Peptide Binds to MHC Class I Protein in the Open Conformer FormThe Journal of Immunology, 2010
- Education of human natural killer cells by activating killer cell immunoglobulin-like receptorsBlood, 2010
- The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humansJournal of Experimental Medicine, 2009
- Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificityBlood, 2009
- HLA antigen changes in malignant cells: epigenetic mechanisms and biologic significanceOncogene, 2008
- Human natural killer cellsBlood, 2008
- Up on the tightrope: natural killer cell activation and inhibitionNature Immunology, 2008
- MHC class I molecules and kirs in human history, health and survivalNature Reviews Immunology, 2005